Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

STERIS plc (S1TE34.SA)

São Paulo - São Paulo Delayed Price. Currency in BRL
43.310.00 (0.00%)
At close: 04:08PM BRST
Advertisement
Full screen
Loading interactive chart...
  • Zacks

    STERIS (STE) to Report Q3 Earnings: What's in the Cards?

    STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend.

  • GlobeNewswire

    STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023

    DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter

  • GlobeNewswire

    STERIS Announces Financial Results for Fiscal 2023 Second Quarter

    As reported revenue was flat; 7% constant currency organic revenue growthAs reported loss per share of ($3.15); adjusted EPS of $1.99As reported loss includes an impairment charge of $490.6 million related to the Dental segment DUBLIN, IRELAND, Nov. 09, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with

Advertisement
Advertisement